ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,107Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 783

$782K Total Retail Price of All Prescriptions

Rank: 102 out of 783

573 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 573 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 573 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,137 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 629 478 1 1
AMLODIPINE BESYLATE 504 412 2 5
LISINOPRIL 451 338 3 4
SIMVASTATIN 434 338 4 3
OMEPRAZOLE 380 282 5 6
ATORVASTATIN CALCIUM 335 274 6 11
METFORMIN HCL 329 249 7 8
HYDROCODONE-ACETAMINOPHEN 301 149 S3 8 2
CRESTOR 280 179 9 27
METOPROLOL TARTRATE 269 219 10 9
HYDROCHLOROTHIAZIDE 255 205 11 12
FUROSEMIDE 248 175 12 7
GABAPENTIN 231 162 13 15
SERTRALINE HCL 221 143 14 22
METOPROLOL SUCCINATE 210 177 15 13
CARVEDILOL 202 148 16 21
PRAVASTATIN SODIUM 179 116 17 14
TRAMADOL HCL 176 136 18 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 165 140 19 33
LOSARTAN POTASSIUM 163 137 20 18
ATENOLOL 141 117 21 17
NEXIUM 139 63 22 28
KLOR-CON M20 133 75 23 48
ALENDRONATE SODIUM 127 102 24 25
TRAZODONE HCL 124 48 25 39
SPIRIVA 124 70 25 59
LOSARTAN-HYDROCHLOROTHIAZIDE 117 96 27 53
GLIMEPIRIDE 113 89 28 34
CITALOPRAM HBR 97 91 29 19
CYMBALTA 96 64 30 35
ZOLPIDEM TARTRATE 95 81 31 23
BYSTOLIC 94 80 32 99
ZETIA 94 59 32 80
PANTOPRAZOLE SODIUM 92 72 34 30
JANUVIA 89 56 35 73
PAROXETINE HCL 86 36 36 69
FLUOXETINE HCL 81 64 37 45
GLYBURIDE-METFORMIN HCL 80 67 R 38 170
PEN NEEDLE 80 67 38 103
EVISTA 75 68 40 92
BUSPIRONE HCL 73 59 41 124
CLONIDINE HCL 70 53 42 60
ADVAIR DISKUS 69 33 43 50
POTASSIUM CHLORIDE 68 62 44 16
JANUMET 63 47 45 217
ISOSORBIDE MONONITRATE ER 63 45 45 40
MELOXICAM 62 52 47 37
LOVASTATIN 62 62 47 58
PROAIR HFA 58 30 49 56
CLOPIDOGREL 57 33 50 29
ROPINIROLE HCL 57 37 50 74
ENALAPRIL MALEATE 56 56 52 68
LANTUS SOLOSTAR 56 34 52 91
OXYCODONE HCL-ACETAMINOPHEN 55 0 S2 54 86
SINGULAIR 54 21 55 90
AMITRIPTYLINE HCL 53 28 R 56 77
CYCLOBENZAPRINE HCL 53 0 R 56 63
PLAVIX 52 28 58 51
SPIRONOLACTONE 50 41 59 57
SYNTHROID 50 40 59 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.